Yamakura T, Lewohl J M, Harris R A
Institute for Cellular and Molecular Biology, University of Texas, Austin 78712-1095, USA.
Anesthesiology. 2001 Jul;95(1):144-53. doi: 10.1097/00000542-200107000-00025.
General anesthetics differentially affect various families of potassium channels, and some potassium channels are suggested to be potential targets for anesthetics and alcohols.
The voltage-gated (ERG1, ELK1, and KCNQ2/3) and inwardly rectifying (GIRK1/2, GIRK1/4, GIRK2, IRK1, and ROMK1) potassium channels were expressed in Xenopus oocytes. Effects of volatile agents [halothane, isoflurane, enflurane, F3 (1-chloro-1,2,2-trifluorocyclobutane), and the structurally related nonimmobilizer F6 (1,2-dichlorohexafluorocyclobutane)], as well as intravenous (pentobarbital, propofol, etomidate, alphaxalone, ketamine), and gaseous (nitrous oxide) anesthetics and alcohols (ethanol and hexanol) on channel function were studied using a two-electrode voltage clamp.
ERG1, ELK1, and KCNQ2/3 channels were either inhibited slightly or unaffected by concentrations corresponding to twice the minimum alveolar concentrations or twice the anesthetic EC50 of volatile and intravenous anesthetics and alcohols. In contrast, G protein-coupled inwardly rectifying potassium (GIRK) channels were inhibited by volatile anesthetics but not by intravenous anesthetics. The neuronal-type GIRK1/2 channels were inhibited by 2 minimum alveolar concentrations of halothane or F3 by 45 and 81%, respectively, whereas the cardiac-type GIRK1/4 channels were inhibited only by F3. Conversely, IRK1 and ROMK1 channels were completely resistant to all anesthetics tested. Current responses of GIRK2 channels activated by mu-opioid receptors were also inhibited by halothane. Nitrous oxide (approximately 0.6 atmosphere) slightly but selectively potentiated GIRK channels. Results of chimeric and multiple amino acid mutations suggest that the region containing the transmembrane domains, but not the pore-forming domain, may be involved in determining differences in anesthetic sensitivity between GIRK and IRK channels.
G protein-coupled inwardly rectifying potassium channels, especially those composed of GIRK2 subunits, were inhibited by clinical concentrations of volatile anesthetics. This action may be related to some side effects of these agents.
全身麻醉药对不同家族的钾通道有不同影响,一些钾通道被认为是麻醉药和酒精的潜在作用靶点。
将电压门控钾通道(ERG1、ELK1和KCNQ2/3)及内向整流钾通道(GIRK1/2、GIRK1/4、GIRK2、IRK1和ROMK1)在非洲爪蟾卵母细胞中表达。使用双电极电压钳研究挥发性麻醉药[氟烷、异氟烷、恩氟烷、F3(1-氯-1,2,2-三氟环丁烷)以及结构相关的非麻醉剂F6(1,2-二氯六氟环丁烷)]、静脉麻醉药(戊巴比妥、丙泊酚、依托咪酯、alphaxalone、氯胺酮)、气体麻醉药(氧化亚氮)和酒精(乙醇和己醇)对通道功能的影响。
ERG1、ELK1和KCNQ2/3通道对相当于挥发性和静脉麻醉药及酒精最低肺泡浓度两倍或麻醉药EC50两倍的浓度,要么仅有轻微抑制,要么无影响。相比之下,G蛋白偶联内向整流钾(GIRK)通道受到挥发性麻醉药抑制,但不受静脉麻醉药抑制。神经元型GIRK1/2通道分别被2倍最低肺泡浓度的氟烷或F3抑制45%和81%,而心脏型GIRK1/4通道仅被F3抑制。相反,IRK1和ROMK1通道对所有测试麻醉药均完全耐受。μ-阿片受体激活的GIRK2通道的电流反应也被氟烷抑制。氧化亚氮(约0.6个大气压)轻微但选择性地增强GIRK通道。嵌合和多个氨基酸突变的结果表明,包含跨膜结构域而非孔形成结构域的区域可能参与决定GIRK和IRK通道在麻醉敏感性上的差异。
G蛋白偶联内向整流钾通道,尤其是由GIRK2亚基组成的通道,受到临床浓度挥发性麻醉药的抑制。这一作用可能与这些药物的某些副作用有关。